In clinical trials, the safety of the combination of lymph node metastasis and adenoviral VEGF-C was demonstrated in a small trial of lymphedema associated with breast cancer (62). The gene discussed is VEGFC; the disease is metastatic malignant neoplasm in the lymph nodes.